Yasutaka Kato
Papers
1
Total Citations
6
H-Index
1
About
Yasutaka Kato is a cancer genomics researcher whose work centers on the molecular mechanisms driving clear cell renal cell carcinoma (ccRCC), with a particular focus on the Von Hippel-Lindau (VHL) tumor suppressor pathway. His most cited study, published in 2022, investigates the complex genomic events underlying multifocal ccRCC. Kato’s research demonstrates how derivative chromosome 3 loss from a t(3;6)(q12;q14) translocation, followed by differential VHL mutations, drives the development of multiple, independent tumors within the same kidney. This work is critical for understanding tumor heterogeneity and the clonal evolution of renal cancer. By elucidating how loss of functional pVHL leads to HIFα accumulation and subsequent tumorigenesis, Kato provides mechanistic insights into a fundamental pathway in ccRCC biology. Though early in his career, with his key paper accumulating 6 citations, his findings offer a compelling framework for future studies on VHL mutation patterns and their role in multifocal disease. Kato’s research has important implications for personalized risk assessment and therapeutic targeting in renal cell carcinoma.
Research Focus
Key Achievements
Top Papers
- 1